Isomorphic Labs

isomorphiclabs.com

Alphabet-backed Isomorphic Labs uses AI to transform drug discovery.

Website LinkedIn Careers

HQLondon

Employees201-1000

Funding$600M

20 active roles

AI / MLFoundation Model ProviderB2B SaaSSeries D+$200M-$1B

About

Isomorphic Labs is Alphabet-backed digital biology company that applies AI to drug discovery. It builds AI-driven drug design engines and platforms to analyze biological data and predict molecule behavior, partnering with pharmaceutical companies to accelerate development and reduce costs.

Active Roles

20

Security Engineering Manager, London or Lausanne

Lausanne; London/Engineering/3d ago

Compound Coordinator - Chemistry Data Generation (Drug Discovery), London

London/Other/6d ago

Bioanalytical Lead, London

London/Other/12d ago

Clinical Program Manager, Cambridge, MA

Cambridge, MA/Product/14d ago

Software Engineer (Inference Platform), London

London/Engineering/17d ago

Senior Security Engineer (AI Safety), London, Lausanne

Lausanne; London/Engineering/17d ago

Bioinformatics Engineer, London

London/Engineering/18d ago

Medical Director, Clinical Development (Oncology), Cambridge, MA

Cambridge, MA/Other/21d ago

Data Curator, London

London/Data & Analytics/48d ago

Technical Program Coordinator, DDMR, London

London/Other/59d ago

Head of Medicinal Chemistry, Drug Design, London

London/Other/67d ago

Support Engineer, London

London/Operations/81d ago

Software Engineer (Data Services), London

London/Engineering/111d ago

Senior Software Engineer (Inference Platform), London

London/Engineering/116d ago

Software Engineer (Compute Platform), London

London/Engineering/151d ago

Research Scientist (Machine Learning), London

London/Data & Analytics/151d ago

Research Scientist (Machine Learning), Lausanne

Lausanne/Data & Analytics/151d ago

Research Scientist (Applied LLMs), London

London/Data & Analytics/151d ago

ML Research Engineer, London

London/Engineering/151d ago

General Application - Register Your Interest

London/Other/151d ago

Key Investors

Alphabet, Thrive Capital, Google Ventures